TQB3126: Clinical Trials

1 trial of TQB3126, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow TQB3126: new trials by email Literature Review of TQB3126 trials Research Report on TQB3126

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
TQB3126 - Breast Cancer
Phase 1 / Phase 2RecruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.3002026-09-122026-10-20

Conditions studied

Breast Neoplasms (1)

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Countries

China (1)